Pseudomonas cepacia has recently emerged as an important pathogen affecting cystic fibrosis (CF) patients. We evaluated three selective media to assess their comparative potential for identification of patients colonized with P. cepacia and for efficacy of detection of P. cepacia in environmental fluids. Test organisms included P. cepacia isolates from CF patients (10 each from two CF centers), non-CF patients (10 isolates), and environmental sources (10 isolates). Microbiologic assays were done by the membrane filter procedure; filters were placed on P. cepacia medium (PCM), OFPBL, TB-T, MacConkey agar (MAC), and blood agar (BA) or Standard Methods (SM) sugar, and colonies were counted after incubation at 30 or 35°C for 72 h. Mean recovery efficiencies (MREs) (mean CFU/ml on selective media compared with CFU/ml on BA controls) for environmental and non-CF P. cepacia and patient isolates from one CF center showed a rank order of PCM > OFPBL > TB-T; for isolates from a second CF center, a rank order of PCM > TB-T > OFPBL was obtained. MREs for CF center isolates were generally lower than for non-CF patients or environmental isolates on P. cepacia-selective media. With MAC, the MREs for each group of CF isolates were extremely low (14 and 2%) compared with those for non-CF patient (47%) or environmental (84%) isolates. In laboratory and field studies, PCM and OFPBL showed good selectivity against bacteria commonly associated with CF patient respiratory secretions. These findings show that selective media should be used in clinical settings where P. cepacia is sought. With environmental fluids from CF centers, P. cepacia-selective media showed low selectivity against a variety of gram-negative water bacteria and appeared to afford little advantage over SM agar for isolating P. cepacia from environmental samples.
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In recent years, Pseudomonas cepacia has emerged as an important pathogen affecting patients with cystic fibrosis (CF) disease (3, 4, 6, 7, 10, 12) . The prevalence of P. cepacia colonization in CF patients has been reported to be as high as 15 to 27% in some CF centers (2, (5) (6) (7) 11) , and colonization has been linked to more rapid clinical deterioration (3, 6, 7, 9) . Historically, Staphylococcus aureus and Pseudomonas aeruginosa have constituted the most significant pathogens routinely isolated from the sputum samples of CF patients (5) (6) (7) 12) . Because P. cepacia tends to grow slowly and to exhibit variable colony morphology on media commonly used in clinical laboratories for sputum culture, this organism is easily obscured by overgrowth of mucoid P. aeruginosa and other respiratory pathogens or overlooked because of the morphologic similarity of P. cepacia colony variants to S. aureus (1, 2, 7, 9) . Similarly, efforts to define the role of the environment in the acquisition and transmission of P. cepacia in CF patients have been hampered by overgrowth of other gram-negative bacteria taken from environmental fluids from CF centers and plated on standard laboratory media (1, 2, 7, 10, 14) .
With the development of media selective for P. cepacia (2, 5, 13, 14) , increased recovery of P. cepacia from the sputum samples of CF patients and from environmental sources has been reported by a number of centers (1, 2, 5, 9, 13 Hospital Infections Program, Centers for Disease Control, in collaboration with the Cystic Fibrosis Foundation, to assess the national incidence and significance of P. cepacia colonization in CF patients.
The studies reported here were designed to provide data for the development of recommended standardized microbiologic procedures for screening for P. cepacia in CF centers participating in the national prospective study, in order to minimize bias and ensure greater accuracy in identifying cases. These studies included: (i) comparison of quantitative recovery of P. cepacia isolates from CF and non-CF patients and environmental sources on P. cepaciaselective and routine clinical laboratory media; and (ii) evaluation of the efficacy of P. cepacia-selective media in isolating P. cepacia from sputum samples from patients and from environmental fluids containing mixed microbial flora by streak-plating and membrane filtration procedures.
MATERIALS AND METHODS
Media. Selective media with bacteriostatic dyes, antibiotics, or low pH have been described for the selective isolation of P. cepacia, and the following were evaluated to determine their efficacy for recovery of P. cepacia: (i) P. cepacia medium (PCM) (21), containing crystal violet, polymyxin B, and ticarcillin (pH 6.2); (ii) OFPBL (13) To assess the efficacy of selective media for detection of environmental P. cepacia, we assayed (MF procedure) environmental fluids obtained from one CF center with SM, PCM, OFPBL, and TB-T media and from a second CF center with SM, PCM, and OFPBL media.
Identification of isolates. All P. cepacia isolates from CF patient sputum and environmental samples were presumptively identified with a screening set of six conventional biochemical tests (oxidation of glucose, lactose, and manni- 
RESULTS
Growth studies. Overall, PCM appeared to be most effective in recovering pure cultures of P. cepacia strains, irrespective of the source of isolates ( Table 1) . Comparison of MRE (mean CFU/ml) on selective media compared with CFU/ml on BA controls showed higher recovery on PCM than on TB-T for isolates from patients from center A (P < 0.001, Student's t test), non-CF patient isolates (P = 0.02), and environmental isolates (P = 0.03). MREs on OFPBL were greater than on TB-T for center A isolates (P = 0.02) and for environmental isolates (P = 0.03); for non-CF patient isolates, the difference was not significant (P = 0.05). With center B isolates, differences in MREs among the three selective media were not statistically significant. In comparing recovery of all CF patient isolates (n = 20) with non-CF isolates (n = 20) on each of the three selective media, OFPBL showed significantly lower recovery for CF isolates (P < 0.01); differences with PCM and TB-T were not significant. P. cepacia isolates from CF and non-CF patients showed poor recovery on MAC, a medium routinely used in clinical laboratories for primary isolation (Table 2) . MREs for each group of CF isolates were extremely low (14 and 2%) compared with non-CF patient (47%) or environmental (84%) isolates.
Tests to assess the ability of P. cepacia-selective media to inhibit growth of non-P. cepacia organisms commonly found in patient respiratory secretions showed that with inocula of 1 x 103 to 1 x 104 CFU/ml, none of 17 strains examined was able to grow on PCM (Table 3 ). On OFPBL, P. maltophilia grew readily, and viable counts of P. aeruginosa were reduced by a factor of 102 when compared with that for BA controls. Further studies with P. maltophilia and P. aeruginosa showed that at high levels of inoculum (1 x 106 to i x 107 CFU/ml), P. maltophilia could be recovered on PCM (103 CFU/ml), whereas P. aeruginosa continued to show no growth.
A comparison of MREs for P. cepacia strains from mixed microbial suspensions (Table 4) (50-ml sample portions) for any of the samples. On OFPBL, viable counts of 5.1 x 100 and 1.4 x 100 CFU/ml were obtained, respectively, in shower and drinking fountain samples. P. cepacia was not identified in any of these samples. Sterile rinses (CDW) of tubing used in pulmonary function-testing machines before and after use showed no detectable organisms. Nebulizer fluids (n = 2) remaining at the end of treatment of the patient showed viable counts of 2.0 x 10-1 and 3.5 x 101 CFU/ml on SM agar. In this latter sample, P. cepacia was detected on PCM (9.3 x 100 CFU/ ml), OFPBL (3.0 x 100 CFU/ml), and SM agar (1.0 x 101 CFU/ml).
DISCUSSION
With the recent increase in the incidence of respiratory infections and continued reports of accelerated clinical deterioration and poorer prognosis in CF patients colonized with P. cepacia (3, 4, 6, 10, 11) , the question of how P. cepacia is acquired has become a major area of concern. P. cepacia is ubiquitous, being found in a wide variety of natural aquatic and soil environments, as well as in hostile environments, such as aerosol antibiotics, topical anaesthetics, and disinfectants (4, 5) . Although studies have sug- (5, 6, (10) (11) (12) .
To elucidate epidemiologic factors for P. cepacia in CF patients, methods of detecting P. cepacia must be sensitive and reproducible. This requires selective media for P. cepacia that have a high efficiency for recovery of P. cepacia and the ability to inhibit background contaminants in the mixed microbial populations typically found in the sputum samples of CF patients and in environmental fluids (2, 7, 14) . It also requires that such media be easily prepared or readily available commercially, if they are to be routinely used by clinical laboratories. One of the media reported to be highly selective for P. cepacia, contained a chemical selective agent (C390) that was not readily available for routine laboratory procedures, and this medium was not included in the study (14) .
In tests to compare the sensitivity of the three selective media for recovering known numbers of P. cepacia, differences in recovery efficiency were observed between two groups of isolates from two CF centers, as well as between CF-patient, non-CF patient, and environmental isolates. This may reflect differences in genetic makeup and physiologic characteristics of P. cepacia strains or in the type or frequency of usage of prescribed antibiotics so that predominant subtypes become established in different CF centers. This may further reflect differences in the adaptive mechanisms that allow P. cepacia to colonize CF patients, in contrast to mechanisms that allow P. cepacia to grow in natural fluid environments and to survive in such hostile environments as dyes, preservative solutions, antiseptics, and disinfectants (4) .
PCM showed good inhibition of pure cultures of bacterial strains most commonly found in the respiratory secretions of CF patients and allowed good recovery of P. cepacia when mixed suspensions of organisms were tested. TB-T similarly showed good inhibition, whereas OFPBL only minimally inhibited P. aeruginosa, P. maltophilia, and Klebsiella spp. Recovery rates of P. cepacia isolates (center B) from mixed suspensions were extremely low both on OFPBL and TB-T. PCM was previously shown to have a good recovery efficiency (75.8%) in quantitative studies using six P. cepacia isolates from the sputum samples of CF patients (2) . In another study (1) , comparable recovery of P. cepacia taken from the sputum samples of CF patients and plated on PCM and OFPBL was reported; however, no quantitative data from studies with known numbers of P. cepacia or other organisms were presented.
PCM, OFPBL, and TB-T may not have similar selectivity for P. cepacia in environmental fluids containing high levels of naturally occurring gram-negative water bacteria. Isolates from environmental fluids that grew on these media (up to 104 CFU/ml) included Alcaligenes and Achromobacter spp., VOL. 26, 1988 on October 28, 2017 by guest http://jcm.asm.org/ P. paucimobilis, P. stutzeri, P. mesophilica, P. pickettùi, P. putida, P. maltophilia, P. aeruginosa, Flavobacterium spp., molds, and yeasts, These findings are consistent with those reported by other investigators (1, 7, 13) . In addition, when P. cepacia was the predominant organism present, SM agar appeared to be as effective as PCM or TB-T in recovering P. cepacia from environmental fluid samples.
It is interesting to note that MAC, a commonly used primary isolation medium, did not support good growth of laboratory strains of P. cepacia isolated from CF patients and was not effective in isolating P. cepacia from fresh sputum samples of P. cepacia-colonized CF patients; these results are consistent with those of other studies reporting its low sensitivity and selectivity (2, 9, 13) .
Standardized procedures in processing sputum specimens and environmental fluids are needed, because the techniques now used vary from simple streak-plating of various amounts of raw sputum (e.g., calibrated loop, swab, and pipette [9] ), to homogenizing and diluting sputum before streak plating. In addition, environmental fluids are frequently treated as clinical specimens; volumes as low as 0.01 or 0.1 ml are cultured by spread plating. Not infrequently, sputum may be refrigerated for an unspecified length of time before microbiologic assays; this can affect either the quantity or type of organisms recovered (8) . We found that overnight refrigeration of CF patient sputum resulted in reduced recovery of P. cepacia on PCM and OFPBL media by streak-plating methods. Membrane filter procedures were found to be efficient for the microbiologic assay of either sputum samples or environmental fluids.
In summary, these studies confirm that the use of selective media, such as PCM or OFPBL, which were developed for use in clinical settings for the isolation of P. cepacia provide greater sensitivity and reproducibility in detecting P. cepacia in the sputum specimens of CF patients. The findings also suggest that there is probably a need for an improved medium for detecting P. cepacia in environmental specimens.
